Lenalidomide

argonaute RISC catalytic component 2 ; Homo sapiens







4 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33284947 Quantitative expression of Ikaros, IRF4, and PSMD10 proteins predicts survival in VRD-treated patients with multiple myeloma. 2020 Dec 8 1
2 29788898 Treatment of Lymphoid and Myeloid Malignancies by Immunomodulatory Drugs. 2019 1
3 30111438 [Molecular Mechanism of CRBN in the Activity of Lenalidomid eagainst Myeloma--Review]. 2018 Aug 1
4 27142104 Expression of the cereblon binding protein argonaute 2 plays an important role for multiple myeloma cell growth and survival. 2016 May 3 1